Biography

1.Research

The research is about the pathogenesis of cardiovascular diseases - basic and clinical. Includes:

a. Prevention and treatment of hypertension mediated organ damage; b. Relationship between new serum markers in patients with heart failure or left ventricular remodeling and cardiac function; c. New techniques for the treatment of ischemic cardio-vascular diseases.

2.Educational Background

1)1984/09-1989/07 Tianjin Medical University,Department of medicine（8 years）,Master's degree;

2)1981/09 - 1984/07Nankai University Department of biology, pre-med;

3.Work Experience

2005/05-now Tianjin Union Medical Center (Nankai University Affiliated Hospital), Department of cardiology, Professor, director, vice president of hospital

2001/01-2005/05 Tianjin second central hospital, cardiac center, Professor，vice director

1989/08-2000/12 Tianjin first central hospital, Department of cardiology, resident,doctor, vice professor

4.Awards

1)Second prize of Tianjin science and technology progress award: Research on the basis and application of new therapy for diabetes complicated with cardiovascular disease (2016JB-2-044-R3):rank 3;

2)Third prize of Tianjin scientific and technological progress: Research on the repair of organ damage by the umbilical cord mesenchymal stem cells regulated by Traditional Chinese medicine for tonifying kidney (2017JB-3-103-R4) : rank 4;

5.Social Service

1)Board of director of Chinese female doctor association

2)Board of director in Tianjin medical association

3)Vice chairman of Cardiovascular disease affiliated Tianjin medical association

4)Vice chairman of ECG physiological and pacemaker association in Tianjin.

5)Member of China emergency thoracic vascular anesthesia and recovery branch committee

6)Member of pacemaker and electrophysiology of biomedical engineering institute professional committee standing committee of the heart rhythm society (Tianjin)

7)Vice chairman of Cardiovascular disease combine Traditional Chinese and western medicine institute

8)Member of Professional degree training guidance committee of Nankai university

9)Peer-Reviewed Journal Papers Editor：“Tianjin medicine”，“Drug and Clinic”

Achievements

1)Huang A, Qi X#, Hou W, Qi Y, Zhao N, Liu K. Prognostic value of sST2 and NT-proBNP at admission in heart failure with preserved, mid-ranged and reduced ejection fraction. Acta Cardiol. 2017;25:1-8. (IF=0.808)

2)Jiao Li, Yameng Cui, Anan Huang, Qi Li, Wenjun Jia, Keqiang Liu, Xin Qi#. Additional Diagnostic Value of Growth Differentiation Factor-15 (GDF-15) to N-Terminal B-Type Natriuretic Peptide (NT-proBNP) in Patients with Different Stages of Heart Failure. Medical Science Monitor. 2018; 24:4992-4999. (IF=1.894)

3)Yameng Cui, Xin Qi#, Anan Huang, Jiao Li, Wenguang Hou, Keqiang Liu. Differential and Predictive Value of Galectin-3 and Soluble Suppression of Tumorigenicity-2 (sST2) in Heart Failure with Preserved Ejection Fraction. Medical Science Monitor. 2018; 24:5319-5146. (IF=1.894)

4)Yameng Cui, Caihong Li, Chao Zeng, Jiao Li, Zhenyu Zhu, Wanli Chen, Anan Huang, Xin Qi#. Tongmai Yangxin Pills Anti-oxidative Stress Alleviates Cisplatin-Induced Cardiotoxicity: Network Pharmacology Analysis and Experimental Evidence. Biomedicine & Pharmacotherapy. 2018; 108:1081-1089. (IF=3.457)

5)Li Q, Qi X*, Jia W. Inhibition of iNOS protects cardiomyocytes against coxsackievirus B3-induced cell injury by suppressing autophagy. Biomed Pharmacother. 2017;91:673-679. (IF=2.759)

6)Liu D, Ji S, Li H, Hong L, Kong D, Qi X*,Ding D*. Cellular membrane-anchored fluorescent probe with aggregation-induced emission characteristics for selective detection of Cu2+ ions. Faraday Discuss. 2017 Feb 1;196:377-393. (IF=3.588)

7)Liu D, Qi X*, Li Q, Jia W, Wei L, Huang A, Liu K, Li Z. Increased complements and high‑sensitivity C‑reactive protein predict heart failure in acute myocardial infarction. Biomedical Reports, 2016; 5:761-765.

8)Song X, Liu D, Cui J, Zhou M, Wang H, Liu N, Qi X *, Li Z*. Identification of Stem-Like Cells in Atrial Myxoma by Markers CD44, CD19, and CD45. Stem Cells International, 2016; 2016:2059584. (IF=3.54)

9)Li Q, Qi X*, Jia W. 3,3’5-triiodothyroxine inhibits apoptosis and oxidative stress by the PKM2/PKM1 ratio during oxygen-glucose deprivation/ reperfusion AC16 and HCM-a cells T3 inhibits apoptosis and oxidative stress by PKM2/PKM1 ratio. Biochemical and Biophysical Research Communications, 2016; 475:51-56. (IF=2.466)

10)Jia W, Qi X*, Li Q. Association Between Rs3807989 Polymorphism in Caveolin-1 (CAV1) Gene and Atrial Fibrillation: A Meta-Analysis Association. Med Sci Monit, 2016; 22:3961-3966. (IF=1.585)

11)Zhang J, Wang G, Mao D, Han A, Xiao N, Qi X*, Ding D* and Kong D. Targeted In Vivo Imaging of Mouse Hindlimb Ischemia Using Fluorescent Gelatin Nanoparticles. Journal of Nanomaterials. 2015; 2015: 1-7. (IF=1.871)

12)Liu N#, Qi X#, Han ZB, Liang L, Kong DL, Han ZC, Zhao SH, He ZX*, Li ZJ *. Bone Marrow Is a Reservoir for Cardiac Resident Stem Cells. Scientific Reports, 2016; 6:28739. (IF=5.228)

13)Zhang X, Zhu D, Wei L, Zhao Z, Qi X, Li Z, Sun D. OSM Enhances Angiogenesis and Improves Cardiac Function after Myocardial Infarction. Biomed Res Int. 2015; 2015:317905. (IF=2.476)

14)He N, Xu Y, Du W, Qi X, Liang L, Wang Y, Feng G, Fan Y, Han Z, Kong D, Cheng Z, Wu JC, He Z, Li Z. Extracellular Matrix can Recover the Downregulation of Adhesion Molecules after Cell Detachment and Enhance Endothelial Cell Engraftment. Sci Rep. 2015;5: 10902. (IF=4.2589)

Projects

1)Risk stratification and treatment strategy of early damage of heart and kidney in hypertensive patients, 16ZXMJSY00060, major special project of Tianjin science and technology committee,2016/10-2016/09, ranking No.1

2)Protein nanoparticle imaging and treatment of ischemic diseases with natural tendency to hypoxia, National natural science foundation project, 31870999, 2019.01-2022.12, ranking No.2

3)Relationship between the level of new serum markers in patients with heart failure and left ventricular remodeling and cardiac function, Tianjin public health bureau, 15KG110, 2015/10-2018/10, ranking No.1 finished.

4)Study on the relationship between PWV, BAI and coronary artery disease in patients with angina pectoris and blood stasis syndrome, Tianjin administration of traditional Chinese medicine, 2015068,2015/10-2017.09, ranking No.1 finished.

5)Relationship between serum complement level and vascular inflammatory factors in patients with acute myocardial infarction, Tianjin public health bureau, 2014KZ052,2015.01-2016.12, ranking No.1 finished.

6)A study on the correlation between the level of new molecular markers and syndrome differentiation in heart failure patients, Tianjin administration of traditional Chinese medicine, 20142102, 2011.10-2014.8, ranking No.1 finished.

7)Multimodal molecular imaging study of human embryonic stem cells (hESC) transplantation for the treatment of myocardial infarction mechanism, National natural science foundation project, 81371620, 2014.01-2017.12, ranking No.2, finished.